Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Ozempic and Wegovy are not compounded and are registered trademarks of Novo Nordisk
2018;142(4):481e488e
While many industry watchers were hoping the oral equivalents would be more financially palatable, they're roughly the same cost as injectables for employers that offer them through insurance
But trial results and routine real-world treatment aren't identical, and regulatory review still matters
Insurance and prior authorization Insurance coverage for retatrutide is not currently available through ordinary prescription-benefit channels because retatrutide is not FDA-approved for any indication
Homegrown firms are quickly moving via Phase 3 trials to challenge early market leaders, ensuring that Chinese companies will secure a major foothold in one of the world's fastest-growing drug classes
US$ 23.16
US$ 22.80
US$ 28.69
US$ 22.77
US$ 25.74
US$ 26.40
US$ 28.14
US$ 21.68
